10x Genomics revenue and financials
$80.66Change from previous close: −17.47%Absolute change: −$17.08
In the fiscal year ended December 2025, 10x Genomics reported revenue of $642.82M (+5.25% year over year). The net loss was $43.54M.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +5.25%
- 2025 vs 2024
- Net margin
- -6.8%
- 2024: -29.9%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 151 | 151 | 166 | 149 | 173 | 155 | 165 | 152 | 153 | 141 | 184 | 154 |
| Cost of revenue | 38.5 | 44.7 | 52.9 | 48.7 | 47.8 | 49.4 | 54.1 | 45.3 | 48.9 | 47.8 | 68.2 | 58.1 |
| Gross profit | 112 | 106 | 113 | 100 | 125 | 105 | 111 | 106 | 104 | 93.2 | 116 | 95.5 |
| Selling, general and administrative | 78.7 | 66.4 | 73.0 | 74.7 | 74.4 | 89.7 | 92.7 | 81.7 | 83.0 | 84.7 | 88.9 | 82.4 |
| Research and development | 56.8 | 56.8 | 55.8 | 57.2 | 61.2 | 64.2 | 67.0 | 66.2 | 62.9 | 67.9 | 60.7 | 66.5 |
| Operating income | -23.0 | -17.0 | -15.6 | -31.5 | -10.6 | -48.5 | -48.7 | -41.5 | -41.7 | -59.4 | -33.8 | -53.4 |
| EBIT | -23.0 | -17.0 | -15.6 | -31.5 | -10.6 | -48.5 | -48.7 | -41.5 | -41.7 | -59.4 | -33.8 | -53.4 |
| EBITDA | -13.3 | -7.1 | -5.6 | -21.2 | -2.8 | -40.5 | -40.0 | -32.5 | -32.8 | -50.2 | -24.1 | -44.0 |
| Interest expense | 0.0 | — | — | — | 0.0 | 0.0 | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Pre-tax income | -18.6 | -12.8 | -15.2 | -28.2 | 37.0 | -33.5 | -48.4 | -34.4 | -37.1 | -57.8 | -46.6 | -91.7 |
| Income tax | -0.7 | 0.6 | 1.1 | -0.7 | 2.5 | 0.9 | 0.6 | 1.3 | 0.8 | 2.1 | 2.4 | 1.2 |
| Net income | -17.9 | -13.5 | -16.3 | -27.5 | 34.5 | -34.4 | -49.0 | -35.8 | -37.9 | -59.9 | -49.0 | -93.0 |
| Net income to common shareholders | -17.9 | -13.5 | -16.3 | -27.5 | 34.5 | -34.4 | -49.0 | -35.8 | -37.9 | -59.9 | -49.0 | -93.0 |
| Basic EPS | -0.14 | -0.10 | -0.13 | -0.22 | 0.28 | -0.28 | -0.40 | -0.30 | -0.32 | -0.50 | -0.41 | -0.79 |
| Diluted EPS | -0.14 | -0.10 | -0.13 | -0.22 | 0.28 | -0.28 | -0.40 | -0.30 | -0.32 | -0.50 | -0.41 | -0.79 |
| Average shares (basic) | 130 | 128 | 127 | 126 | 124 | 123 | 122 | 121 | 120 | 119 | 119 | 118 |
| Average shares (diluted) | 130 | 128 | 127 | 126 | 125 | 123 | 122 | 121 | 120 | 119 | 119 | 118 |